BioSpace News Archive

Servier Pharmaceuticals, a leader in hematology, achieves first major milestone in the solid tumor category Company has grown U.S. oncology business by nearly 20% in the past two years

The award will support young investigators interested in community-based participatory research whose projects address disparities and promote health equity in lung cancer

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that the Company has completed patient enrollment in the phase 2 PORT study.

According to the report, the global contrast enhanced digital mammography market was valued at US$ 244.5 Mn in 2018 and is projected to expand at a CAGR of ~11% from 2019 to 2027.

Liberal regulatory policies by governments and international agencies and the rising number of research studies will continue to boost the market growth.

Aesthetic medicine is a term used mainly for specialty services that focus on improving cosmetic appearance through the treatment of various conditions such as excess fat, moles, scars, and others.

Zealand Pharma A/S a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, announced that it will host a conference call on May 12, 2021 at 4 pm CET following the announcement of results for the first quarter of 2021

Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX) , a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today provided financial, clinical and operational updates for the first quarter ended March 31, 2021.

BridGene Biosciences, Inc. , a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules for high value, yet traditionally undruggable targets, announced today it has raised $12 million in a Series A private financing round led by Wedo Venture Partners

StageZero Life Sciences, Ltd., a specialist in PCR testing dedicated to the early detection of multiple diseases through whole blood, announced it will distribute via its partner Ichor Blood Services through a Canadian retail outlet, COVID-19 PCR saliva test kits in British Columbia, Alberta, Saskatchewan, Manitoba and Ontario beginning May 5.